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RNA interference (RNAi) is a highly conserved and sequence-specific process for 
regulation of gene expression. At the heart of the RNAi machinery lie 21-24 nt small 
non-coding RNA molecules which are able to downregulate the expression of cognate 
sequences, by causing degradation or translational repression of mRNAs. These non-
coding RNAs act via the effector RNA-induced silencing complex (RISC), which 
includes core proteins such as the Argonautes (AGOs). Two Chlamydomonas reinhardtii 
RNAi-defective mutants, Mut13-2 and Mut20, show deletions of various domains of the 
Tudor Staphylococcal Nuclease 1 (TSN1) gene. TSN1 has already been recognized as a 
component of the RNA-induced silencing complex in metazoans. However, the specific 
function of this protein in the RNAi pathway remains undefined. In this study we report 
that TSN1 is essential for RNAi in Chlamydomonas reinhardtii. Interestingly, the two 
examined mutants show a widely different profile of endogenous miRNAs. The small 
RNAs are almost completely depleted in the case of Mut20 but are only slightly reduced 
in level in Mut13-2. Successful complementation with an epitope-tagged TSN1 and 
recovery of RNAi-induced phenotypes was achieved in Mut13-2 but not in Mut20.  
Through immunofluorescence microscopy, the epitope-tagged TSN1 protein was found 
to be predominantly cytoplasmic, although some degree of nuclear localization was also 
observed, which supports its association with the RISC as reported in metazoans. Yet, co-
immunoprecipitation assays with the epitope-tagged TSN1 did not show association with 
AGO3, a core component of the RISC in Chlamydomonas. It is tempting to hypothesize 
that TSN1 may play an accessory role in the assembly of the RISC, perhaps in the 
loading of small RNAs onto Argonautes. This interpretation would be consistent with the 
reduced level of small RNAs in the mutant backgrounds and the lack of high affinity 
interactions with AGO proteins. However, elucidating the exact role of TSN1 will require 
further investigation. 
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    LITERATURE REVIEW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
A. INTRODUCTION 
 
 
Ever since its discovery in Caenorhabditis elegans, RNA interference (RNAi) has 
emerged as a major pathway for regulation of gene expression as well as a potent 
experimental tool (1). It is an evolutionarily conserved and a highly sequence-specific 
process for inhibition of gene expression, either at the level of transcription, mRNA 
stability or translation (2). Such potent inhibition of target mRNAs by RNAi has heralded 
several studies directed towards deciphering gene function via gene silencing. In case of 
genetic analyses, RNAi has been widely successful by providing a reverse genetics 
approach to functional genomics questions and in genome sequencing projects of various 
organisms such as C. elegans, Drosophila melanogaster and Humans (3-5). Genome-
wide RNAi high-throughput screens (RNAi-HTS) in Drosophila, mammalian cells have 
become the primary method for high-throughput analysis gene function and have led to 
answering pertinent biological questions in developmental biology, signal transduction, 
metabolic regulation among others (6,7).  Inhibition of a specific mRNA by RNAi has 
also proven to have valuable potential in pharmacological studies and also from a drug 
discovery perspective, whereby the effector molecules of RNAi – small interfering RNAs 
(siRNAs) seem to have an upper hand compared to small molecules and conventional 
drug therapies (8).  
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 Deciphering the function of various components of the RNAi pathway has been 
essential towards progressive understanding of this important gene silencing mechanism. 
Primarily hinted in plants to begin with (9), RNAi is now found to be prevalent in almost 
every eukaryotic species.  Besides affecting mRNA turnover and protein synthesis and 
stability in general, RNAi and its associated pathways are also known to regulate 
response to pathogens, transposons and involvement in heterochromatin formation 
(10,11). Post-Nobel prize winning work by Mello and Fire for characterization of double-
stranded RNA (dsRNA) as the trigger for such sequence-specific gene silencing in  C. 
elegans (1), cell-free systems from Drosophila, human cell lines and wheat germ, have 
greatly contributed towards our knowledge of  the mechanistic details of the RNAi 
pathway (12-16). One such contribution from these studies is the biochemical 
identification of the RNA-induced silencing complex (RISC) (14).  This multi-protein 
complex along with different other components acts as the focal point for mRNA 
targeting. The dsRNA trigger for RNAi is processed by an RNase III-type 
endoribonuclease known Dicer, into small (18-25 nt) interfering RNAs (siRNAs) (17) or 
certain 20-24 nt long microRNAs (miRNAs) (18-20). These siRNAs or miRNAs in 
association with the RISC form a siRISC or miRISC respectively and are key features in 
post-transcriptional regulation of gene expression in both metazoans and in plants (21). 
Such small RNAs have been shown to even regulate several critical junctions of life such 
as developmental timing, hematopoiesis, organogenesis, apoptosis and even 
tumorigenesis (22).  
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B. The RNAi mechanism 
 
The RNAi machinery comprises of three major components – RNase III-like Dicer 
endoribonuclease, a small (guide) RNA and Argonaute protein (21).  Hamilton and 
Baulcombe were first to report the presence of ~25 nt small non-coding RNAs which 
assist in sequence-specific defense against viral and cellular mRNAs via their sequence 
complementarity to the target mRNAs (17,23). While the processing of these small non-
coding RNAs via Dicer (RNAse III activity) mostly occurs to a certain extent within the 
nucleus of the cell in most organisms, the assembly of the RISC holo-enzyme and target 
mRNA cleavage or repression is found to occur in the cytoplasm (20,21). The RNA-
induced silencing complex (RISC) has been reported to have a wide range of size 
distinctions in various studies 160-550 kDa to 80S (16,21,24-28). Such size differences 
definitely suggest the complexity of the RISC in terms of varying in composition from 
one organism to the other. In part, such complexity has also hindered a more complete 
and universal view of the RISC assembly. But among all its various components, a 
ubiquitous one has been – the Argonaute (AGO) family of proteins with their PAZ and 
PIWI domains (29). 
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i. Dicer – the endoribonuclease 
 
Compartmentalization of the canonical RNAi machinery as an upstream (nuclear) or a 
downstream (cytoplasmic) process has demarcated the silencing mechanism into distinct 
phases of dsRNA processing and RISC assembly (21,30,31). Even so, there lay 
differences among animals and plants in terms of the components of RNAi as well as in 
the different phases of the pathway. But a significant linker among such discrepancies is 
the requirement of Dicer as part of dsRNA processing as well as RISC function (28,32).  
Dicer is a class of RNAse III enzymes, which shows specificity for dsRNA (31,33). In 
addition to having two RNAse III domains, Dicer contains an N-terminal DEAD/DEAH 
box RNA helicase /ATPase domain, DUF 283 (Domain of Unknown Function), a 
dsRNA-binding domain (31,33). A number of Dicer homologues also possess a PAZ 
domain which helps in recognition of the 2 nt 3’ overhang of the siRNA duplex and its 
incorporation into the RISC effector complex (34). PAZ stands for 
Piwi/Argonaute/Zwille, which are the three proteins, found to have this domain in 
common (35,36). The two RNAse III domains of dicer are dimerized with the help of 
PAZ and the dsRNA-binding domain to form a processing center which helps in the 
formation of products with 2 nt 3’ overhangs (36). Showing minimal sequence-specificity 
in terms of cleavage, Dicer processes dsRNAs into staggered siRNA duplexes with 3’ 
overhangs having 5’ phosphate and 3’ hydroxyl at the termini of each strand (37-39). 
This siRNA product is then assembled into the siRISC for downstream effects of RNAi 
(14,40).  Dicer is also capable of processing precursor miRNAs into a similar miRISC 
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(41,42). In C. elegans and D. melanogaster, Dicer function requires ATP for activity 
(27,42-44), while mammalian Dicers do not have such requirements (45).  
 
With regards to variability of Dicers, they are found to be present in varying numbers of 
one to four in different organisms (31). In C. elegans, Zebrafish and vertebrates such as 
mouse only one Dicer protein seems to be involved (43,46,47). DCR-1 is the only Dicer 
protein expressed in C. elegans (48), while there are two Dicers paralogues – DCR-1 and 
DCR-2 in D. melanogaster, each having exclusive functions (20,32).  DCR-1 possesses a 
PAZ domain but lacks a functional helicase domain and is found to be essential for 
processing of miRNA precursors as well involved in miRISC-driven translational 
repression, while DCR-2 is responsible for processing siRNA precursors in Drosophila 
(32). Although both these Dicers have been shown to have association with the RISC, at 
least in Drosophila, they seem to have notably varying roles in this effector complex 
(49). In C. elegans, DCR-1 is found to interact with RDE-4 (a dsRNA binding protein), 
RDE-1 (an Argonaute protein) as well as a conserved DExH-box helicase (48). Several 
other studies have also revealed the presence of similar RNA helicases in post-
transcriptional gene silencing. MUT 6 is a DEAH-box RNA helicase found to be 
involved in transposon silencing in Chlamydomonas reinhardtii (50), whereas SDE-3 is 
also a helicase involved in post-transcriptional gene silencing in Arabidopsis thaliana 
(21,48,51). Such RNA helicase activity is required downstream of siRNA formation 
during the repression or cleavage of the target mRNA (52).  RDE-1, an Argonaute 
protein, exerts its RNase H activity for cleaving the passenger strand of the siRNA 
duplex (53), whereas RDE-4 homo-dimerizes and helps to bind preferentially to dsRNAs 
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(48,54). Hence, in C. elegans, it seems that a RDE-4/dsRNA ribonucleoprotein complex 
helps to recruit DCR-1/RDE-1/RNA-helicase complex through interactions between 
RDE-4 and DCR-1 (54).  Another auxiliary dsRNA-binding protein called R2D2 is found 
to interact with and heterodimerize with DCR-2 in Drosophila melanogaster and this 
R2D2/DCR-2 complex is involved in sequence-specific mRNA degradation via siRNA 
binding (32,44). Hence it is evident that R2D2 acts as a sort of connector between the 
initiation and effector stages of the RNAi machinery (21,44). In terms of structure and 
function, R2D2 seems to be similar to the RDE-4 protein in C. elegans which suggests 
that its role is conserved among other organisms as well (21). A similar nuclear localized 
dsRNA binding protein – HYL1 is also known to associate with Dicer and is involved in 
miRNA metabolism in A. thaliana (55). 
 
In Arabidopsis thaliana, there are four Dicer homologues (DCL1-4), and even among at 
least three of them, there is some variability of function (31). DCL1 is required for 
processing precursor miRNAs (56,57), while DCL2 processes virus-specific dsRNAs 
(58), and DCL3 is required for processing endo-siRNAs (58). DCL4 has been shown to 
be involved in trans-acting siRNA biogenesis in association with DRB4 (a dsRNA 
binding protein) as well as in virus-induced silencing (2,59,60). In Chlamydomonas, there 
are three Dicer-like polypeptides, of which DCL1 is shown to be involved in post-
transcriptional silencing of retrotransposons such as TOC1 (61).  A number of Dicers 
such as Drosophila DCR1 and A. thaliana DCL1 also exhibit nuclear localization signals 
suggesting further speciation in the roles of these critical proteins in RNAi (56,62). 
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ii. Small RNAs –  
 
Small duplex RNAs have been depicted as the guide molecules for directing the RISC 
complex towards the target mRNA for its cleavage or translational repression. Although 
the term small RNAs has been widely used to depict such RNAi associated molecules, it 
also refers to other non-coding RNAs such as small nuclear RNAs (snRNAs) and transfer 
RNAs (tRNAs) (19). In fact, a group of small regulatory RNAs known as CRISPR 
(clustered regularly interspaced palindromic repeats) have been characterized in 
prokaryotes, such as bacteria, to interfere with invading viruses (63). The distinction 
between such different types of non-coding RNAs and eukaryotic small RNAs of the 
RNA silencing pathway is their size range of ~ 18-25 nt and association with the 
Argonaute (Ago) family of proteins (64).  Ever since the first small RNA – lin-4 was 
discovered in C. elegans (65,66), a myriad of small RNA species have been characterized 
in a wide array of eukaryotes especially through cloning and sequencing of size-
fractionated RNAs (19,67) and more recently through deep sequencing and 
computational prediction methodologies (68). Although recent multitude of discoveries 
of non-canonical small RNAs have diversified small RNAs into various classes, they can 
be classified in three major classes on basis of biogenesis as well as interacting effector 
proteins into – microRNAs (miRNAs), small interfering RNAs (siRNAs or endo-
siRNAs) and Piwi-interacting RNA (piRNAs) (19).  
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• MicroRNAs - Biogenesis & Characteristics –  
 
miRNAs are an almost ubiquitous class of 20-24 nt small RNAs found in both plants and 
animals, and in association with Ago protein effect post-transcriptional gene regulation 
(18). Despite their similarities, animal and plant miRNAs seem to be quite distinct with 
respect to their sequence, precursor structure, biogenesis and mode of action (19,22,69). 
Some animal miRNA genes are associated in close proximity to each other and as such a 
miRNA cluster is transcribed from a single polycistronic transcription unit (TU) (70), 
while there are other miRNAs which are produced from separate TUs (71). While animal 
miRNA genes are found within exons and introns, plant miRNA genes are mostly 
intergenic and seem to have evolved via inverted gene duplication, spontaneous evolution 
or through generation of miniature inverted-repeat transposable elements (MITEs) (72-
76). 
 Transcription of most miRNA genes is carried out by RNA Polymerase II, which 
generates a capped and polyadenylated primary (pri-miRNA) transcript possessing a 
stem-loop structure (77,78). In animals, pri-miRNA is processed by Drosha (a nuclear 
RNase III-type protein) which cleaves at the stem of the hairpin structure to release 
another ~70 nt short hairpin pre-miRNA (70,79). Drosha associates with DiGeorge 
syndrome critical region (DGCR8) protein (in humans) also known as its homolog – 
Pasha (in D. melanogaster and C. elegans) to form the Microprocessor complex (80,81). 
This complex is able to bind the ~33 bp stem of pri-miRNA and its flanking ssRNA 
regions to carry out cleavage to form a pre-miRNA (82). Alternatively, pre-miRNAs can 
sometimes be generated, in animals, without the help of a microprocessor complex, via 
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splicing of pri-miRNA transcripts releasing introns (mirtrons), which resemble pre-
miRNAs (83,84). The pri-miRNA sequences are stabilized with the help of a DDL 
(dawdle) RNA-binding protein in A. thaliana and SNIP1 (Smad-nuclear interacting 
proteins) in humans (85). In the case of plants, which lack the Drosha and Pasha proteins, 
the processing step from this pri- to pre-miRNA involves DCL1, a double-stranded RNA-
binding protein – HYL1, a C2H2-zinc finger protein – SERRATE (SE) and a nuclear 
cap-binding complex – CBC (86,87). Post-nuclear processing, the pre-miRNA is 
exported into the cytoplasm, in case of animals, (88,89) with the help of a Ran-GTP 
dependent karyopherin protein – Exportin 5 (90). The pre-miRNA is then processed in 
the cytoplasm into a ~22 nt mature miRNA duplex with the help of the Dicer enzyme 
(20,42) which associates with dsRNA-binding protein – LOQS (Loquacious), TRBP 
(Trans-activating response RNA-binding protein) and PACT to make up a part of the 
RISC assembly (91-94). On the other hand, in plants, the pre-miRNA-to-mature miRNA 
duplex excision is carried out by DCL1 in the nucleus (18,71). In Arabidopsis, the mature 
miRNA duplex is stabilized by S-adenosyl methionine-dependent HEN1 
methyltransferases that adds methyl groups at the 3’ terminus of the duplex to prevent its 
uridylation and subsequent degradation by quality control mechanisms in the cytoplasm 
such as the RRP6 exosome subunit or SDN (Small RNA degrading nuclease) (95,96). 
Such mechanisms have also been described in Chlamydomonas reinhardtii (97).  
Subsequently, the plant homolog of Exportin-5, HASTY is responsible for transition of 
the mature miRNA duplex from the nucleus to the cytoplasm (99).  
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 Post Dicer processing, the small RNA duplex becomes associated with an Ago 
protein to generate the RISC effector complex. This process requires specific strand 
selection where the Ago associates with the mature miRNA (guide strand) while the other 
miRNA* (or passenger) strand is degraded (100,101).  The relative thermodynamic 
stability of the two ends of the miRNA duplex determines which one of them is selected 
as the guide strand (102,103).  In case of Drosophila, R2D2 is able to differentiate such 
thermodynamic differences and along with DCR2 assists in strand selection in the RISC 
loading complex (RLC) (44,104), whereas in humans, TRBP and PACT may play similar 
roles (91,93). 
 
Animal miRNAs tend to regulate target mRNA transcripts mostly via imperfect 
complementarity to multiple sites on the 3’ UTR of the target mRNA and subsequent 
translational repression and on some occasions by mRNA decay (19). In some cases, 
miRNAs can also be involved in translational activation (105) and formation of 
heterochromatin (106). A particular seed region of the miRNA (2-7 nts) needs 
complementarity to the target mRNA (in animals) via Watson-Crick base pairing, even 
though there may be mismatches & bulges with respect to target binding (107). On the 
other hand, plant miRNAs have a single, highly complementary target site in the coding 
regions and work mainly via cleavage of the target mRNA (73). In Chlamydomonas 
reinhardtii, mRNA cleavage has also been suggested as the primary mode of regulation 
(108). Certain examples of translational repression have also been observed in plant 
miRNAs (109).  
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• Small interfering RNA (siRNA) - Biogenesis & Characteristics – 
 
The first species of siRNAs was discovered in plants (17) and shortly thereafter it was 
shown that synthetic siRNAs were able to induce an RNAi response (23). Although 
siRNAs employ mechanisms similar to miRNAs for biogenesis and also possess a 
general similarity in their regulation of the target mRNA, there are a few distinctions 
between them. siRNAs are ~21 nt in length and mostly associated with genomic 
protection against invading viral dsRNAs, transposons or transgene triggers and are 
dependent only on Dicer or Dicer-like proteins instead of Drosha (18,19). The precursor 
for the ~21 nt siRNAs has been identified as the canonical inducer of RNAi – the dsRNA 
which could have a multitude of sources (18,110). Besides having exogenous triggers, 
siRNAs have also been shown to be generated endogenously (endo-siRNAs) from 
transposons, sense-antisense transcripts and long stem-loop structures and hence as such 
differ from exo-siRNAs in having a nuclear phase in biogenesis (111-113). For 
generation of endo-siRNAs, plants and worms employ RNA-dependent RNA 
polymerases (RdRps) which is absent in mammals and flies (114). Relatively few 
molecules of dsRNA trigger can induce synthesis of secondary siRNAs (in presence of 
the target mRNA) via such RdRps (110,115). The secondary siRNAs are responsible for 
amplification of the RNAi response and in general lead to systemic silencing throughout 
the organism, leading to silencing of multiple targets (known as transitive RNAi) 
(18,116,117).  
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Nat-siRNAs (natural antisense siRNAs) are generated from convergent 
transcription of the same loci of the sense-antisense transcripts, while trans-acting 
siRNAs (ta-siRNAs) are derived from specific genomic transcripts but separate loci (118-
120). In Arabidopsis, nat-siRNAs accumulation requires RNA-dependent RNA 
polymerases (RDR6), and they are recognized and processed by DCL2 and DCL1 into 
additional ~21 nt nat-siRNAs (120), while the ~21 nt ta-siRNAs are produced with the 
help of RDR6 and DCL4 enzyme (121,122). Other kinds of siRNAs are the 
heterochromatic siRNAs (hc-siRNAs) and repeat associated siRNAs (ra-siRNAs) (123). 
While hc-siRNAs are DCL3/RDR2-dependant and act via AGO4 for maintenance of 
DNA/histone methylation of transposons and chromatin remodeling (124-126), ra-
siRNAs are Dicer-independent and silence retrotransposons and repetitive sequences 
(127).  
 
Dicer 2-LOQS complex is involved in processing of endo-siRNAs in Drosophila 
(similar to the miRNA pathway), whereas exo-siRNAs require Dicer 1-R2D2 association 
(19,44,92). Human exo-siRNAs are associated with AGO1-4 of which only AGO2 has 
been shown to possess slicer activity, whereas Dicer-AGO2 seem to be solely involved 
with endo-siRNAs (128). In a canonical RNAi pathway, the siRNA guides the RISC 
towards the complementary target mRNA degradation. The slicer activity is carried out 
by the Argonaute protein (RNase H-like activity) which cleaves the phosphodiester links 
between target residues to give products with 5’ monophosphate and 3’ hydroxyl termini 
(129). Thereafter, these fragments are acted upon by cellular 5’-3’ exonucleases such as 
XRN1 to completely degrade the target (130). Post-cleavage the target dissociates from 
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the RISC which is now free to act upon additional targets thus, in some cases, showing 
characteristics of a multiple-turnover enzyme (131,132). In cases of partial 
complementarity, siRISCs can initiate silencing via translational repression or 
exonucleolytic degradation similar to miRNAs (18,129).  
 
• Piwi-RNAs (piRNAs) – Biogenesis & Characteristics –  
 
piRNAs are endogenous, germ-cell specific small non-coding RNAs which have a 
distinct size of ~24-29 nts and are shown to associate with Aubergine (AUB) and 
PIWI family of proteins (133).  Mostly identified in Drosophila, mammals and 
Zebrafish, piRNAs are generated from long single-stranded RNA precursors which 
are often produced by intergenic repetitive elements in the genome including 
retrotransposons and hence have a degree of similarity to ra-siRNAs (134). Similar to 
plant miRNAs, these non-coding RNAs are generated from piRNA clusters in 
Drosophila, although the exact mechanism of this primary processing is not clearly 
understood (135,136).  Among the different proteins that interact with piRNAs, MILI 
and MIWI2 are essential for de novo DNA methylation of transposons in germ cells, 
which suggests that piRNAs are also involved in transcriptional gene silencing 
through DNA methylation (137,138). piRNAs have also been shown to be have an 
epigenetic role in transposon silencing,  (139). 
 
 The PIWI clade of proteins possesses a symmetrical dimethyl arginine (sDMA), 
at their N termini, which is recognized by Tudor-domain containing proteins 
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(TDRDs) (140,141). These proteins are essential for germline development and play 
important roles in piRNA metabolism through sDMA binding in PIWI proteins 
although the exact molecular mechanism remains to be deciphered (142,143).  
 
iii. Argonaute & the RISC complex – 
 
At the center stage of the RNAi pathway lays the RISC complex. The RISC was 
originally identified by fractionation of sequence-specific nuclease activity in Drosophila 
extracts (24). Some of its known components include – Argonaute, Vasa Intronic Gene 
(VIG/ MUT70 – the homolog in Chlamydomonas), human Fragile X protein (FXR / 
dFXR – the homolog in Drosophila) and TSN1 (Tudor-Staphylococcal Nuclease) (144-
146). Among these, Argonaute was the ubiquitous component in purifications from 
different species, while the specific biochemical roles of the others such as TSN1 are yet 
to be resolved. Interacting with small RNAs they are known to effect gene silencing in all 
currently elucidated RNAi-related pathways (147). Argonaute proteins consist of four 
domains – N terminal domain, PAZ domain (similar to Dicer enzymes), middle (MID) 
domain and the PIWI domain (148,149). Among these, the PAZ and the PIWI domains 
are conserved and while the PAZ domain (containing an OB fold) is shown to bind 3’ end 
of the guide RNA (150,151), the PIWI domain has an RNase H-like fold which suggested 
Argonautes to have the slicer activity of the RISC (149). The MID and PIWI domains are 
essential towards recognition of the 5’ terminal nucleotide of small RNAs (19,152). 
Argonaute specifically cleaves target mRNA at the phosphodiester linkages between the 
target nucleotides base-paired to the small RNA residues 10 and 11 from the 5’ end 
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(21,153). The RISC loaded with the guide RNA and the specific Argonaute protein is 
capable of multiple rounds of target binding, cleavage in its slicing cycle (147). 
 
Argonautes can be further classified into two major clades – AGO-like (which 
associates with miRNAs and siRNAs) and the PIWI-like (which interacts with piRNAs) 
subfamilies (147). There is also suggestion of a third clade – the group 3 Argonautes that 
are worm-specific and mostly contain non-slicer Argonautes (154).  The numbers of 
Argonaute proteins vary among different organisms. The yeast, Schizosaccharomyces 
pombe, expresses only one Ago1 protein as an active slicer (155). Arabidopsis thaliana 
has ten AGO family members of which two possess slicer activity (126,156), while 
Drosophila melanogaster has five AGO proteins of which AGO1 is involved in miRNA 
accumulation and AGO2 for siRNA production (157,158). On the other hand, C. elegans 
has 27 Argonaute proteins while Chlamydomonas reinhardtii has three (61,159).   
 
The RISC can effect gene silencing via mRNA cleavage as well as translational 
repression. During translational repression, the target mRNA along with AGO proteins is 
sequestered into cytoplasmic foci known as P-bodies or stress granules where the 
Argonaute proteins are able to interact with a P-body component – GW182 (160,161). In 
mammals and C. elegans, miRNAs and AGO proteins are able to co-sediment with 
polyribosomes, which suggest a post-initiation step of regulation of translation (19,162). 
Similar association with polyribosomes has also been demonstrated in Arabidopsis, 
between miRNAs and AGO1 (163). Human AGO2 has been shown to compete with 
eIF4E for binding to the mRNA cap structure, via its similarity to the cap binding motif 
 16 
of the translation initiation factor 4E (164). miRISC mediated silencing can, as such, also 
take place by similarly preventing assembly of transnationally competent 80S ribosomes 
(165).  
 
Purpose of this study: - 
 
RNAi has become a method of choice for down regulating target genes and has a wide 
variety of applications – from medicine to crop improvement. Deciphering the function 
of the various components of RNAi is a crucial step towards fully understanding this 
important gene regulatory mechanism. The unicellular (haploid) green alga 
Chlamydomonas reinhardtii has served as a model organism for understanding the 
various aspects of cell biology and RNAi (123). Moreover, completion of the 
Chlamydomonas genome sequence has greatly assisted in its use as a model system and it 
also possesses functional RNAi machinery (108,166).  Through this study, we have 
aimed to characterize two related RNAi-defective mutants– MUT13-2 and MUT20, 
generated via genetic screens in Chlamydomonas reinhardtii.  
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Figure 1-1. miRNA pathway in animals and plants –  
 
A. Molecular pathway for miRNA biogenesis in plants. Primary (pri-) miRNAs are 
transcribed from MIR genes with the help of RNA Pol II and associates with stabilizing 
protein named Dawdle (DDL). The pri-miRNA is processed into a pre-miRNA with the 
help of DCL1, HYL1 and SE proteins. Post processing the mature miRNAs can also be 
methylated by HEN1 and are exported to the cytoplasm with the help of HASTY (an 
exportin-5 homolog). The guide miRNA is incorporated into the RISC complex in 
association with AGO family of proteins. [Reproduced and modified from - Voinnet, O. 
(2009) Origin, biogenesis, and activity of plant microRNAs. Cell, 136, 669-687]. 
  
B.  Biogenesis of canonical miRNAs in animals. The pri-miRNA is similarly generated 
with the help of RNA Pol II, but the pre-miRNA is formed with the help of a Drosha, 
DGCR8/Pasha. The pre-miRNA then associates with Exportin-5 and is exported out into 
the cytoplasm where it is acted upon by Dicer (DCR1 in flies) to produce the miRNA 
guide strand in association with AGO proteins. [Reproduced and modified from - Kim, 
V.N., Han, J. and Siomi, M.C. (2009) Biogenesis of small RNAs in animals. Nat Rev Mol 
Cell Biol, 10, 126-139.] 
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Figure 1-2. siRNA pathways in plants and animals – 
 
A. ta-siRNA and nat-siRNA in plants. Besides canonical exogenous triggers for 
siRNA response in plants, these are the endogenous responses which result in 
mRNA cleavage. Generated from TAS transcripts or sense-antisense transcripts, 
these siRNAs are dependent on RDR6 for amplification of the silencing response 
and results in specific target mRNA cleavage. 
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B.  siRNAs are also generated by exogenous triggers such viral dsRNAs or 
introduction of synthetic siRNAs. The endonuclease Dicer cleaves the dsRNA to 
generate ~20-25 nt long small RNAs of which one (guide) strand is loaded onto 
the RISC-loading complex along with the Argonaute protein. The Ago protein 
uses the guide strand (having perfect complementarity with target RNA) to direct 
the target mRNA cleavage. [Reproduced and modified from - Vaucheret, H. 
(2006) Post-transcriptional small RNA pathways in plants: mechanisms and 
regulations. Genes Dev, 20, 759-771.] 
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Figure 1-3. Structure of DICER and ARGONAUTE proteins – 
 
A. Dicer is a member of the third class of RNase III family of enzymes and exhibits 
specificity for dsRNA. It contains a N-terminal DEAD/DEAH box RNA helicase 
domain, two Ribonuclease III (RIII) domains, a domain of unknown function 
(DUF 283), a dsRNA binding motif and a PAZ domain. The two RIII domains of 
Dicer dimerize to form a catalytic center responsible for cleaving dsRNAs. Most 
but not all Dicers have PAZ domains. The adjoining figure shows the front and 
side views of crystal structure of Giardia Dicer along a modeled dsRNA substrate 
and the red arrows show the point of cleavage. [Reproduced and modified from -  
Jaronczyk, K., Carmichael, J.B. and Hobman, T.C. (2005) Exploring the functions 
of RNA interference pathway proteins: some functions are more RISCy than 
others? Biochem J, 387, 561-571; Macrae, I.J., Li, F., Zhou, K., Cande, W.Z. and 
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Doudna, J.A. (2006) Structure of Dicer and mechanistic implications for RNAi. 
Cold Spring Harb Symp Quant Biol, 71, 73-80.] 
 
B. Domain structure of Argonaute family of proteins. They possess four major 
domains – N-terminal domain, PAZ (Piwi/Argonaute/Zwille), MID (middle) 
domain and PIWI domain. The adjoining figure shows the crystal structure of 
Argonaute protein in P. furiosus. The domains have similar color-coding as in the 
key. The active site residues are listed as – Asp-Asp-His. [Reproduced and 
modified from - Tabara, H., Yigit, E., Siomi, H. and Mello, C.C. (2002) The 
dsRNA binding protein RDE-4 interacts with RDE-1, DCR-1, and a DExH-box 
helicase to direct RNAi in C. elegans. Cell, 109, 861-871; Tolia, N.H. and Joshua-
Tor, L. (2007) Slicer and the argonautes. Nat Chem Biol, 3, 36-43. ] 
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INTRODUCTION 
 
The RNA-induced silencing complex (RISC) lies at the heart of the RNAi machinery, 
and yet the function of a number of its components is not completely understood. In order 
to decipher the function of such various components, we screened for RNAi-defective 
mutants in Chlamydomonas reinhardtii. We first generated the Maa7-IR44s strain which 
expresses an inverted repeat (IR) transgene homologous to a ~60 bp region on the 3’ 
UTR of the MAA7 gene (which codes for tryptophan synthase ß subunit) (1). The strain 
Maa7-IR44s acts via translational repression whereby the level of the tryptophan 
synthase ß subunit protein is reduced without changes in the corresponding transcript 
amount (unpublished data). We next isolated, mutants defective in down-regulation of the 
Maa7 protein by using random insertional mutagenesis. Two related mutants – Mut13-2 
and Mut20 – were found to be deleted for a number of the essential domains of the gene 
Tudor Staphylococcal Nuclease 1 (TSN1) also known as P100 (transcriptional co-
activator protein 100) or SND1 (staphylococcal nuclease and tudor domain 1) in 
mammals, Drosophila, C. elegans, as well as in fission yeast (2). Through this study we 
have sought to identify the molecular role of TSN1 in the RNAi pathway.  
 
TSN1 is a highly conserved and ubiquitous protein in eukaryotes and is found to be 
involved in various cellular processes such as transcription, spliceosome assembly, RNA 
stability, programmed cell death as well as in RNAi. In mammals, it has been identified 
as a transcriptional co-activator interacting with several transcription factors such as 
EBNA-2 (3), c-Myb (4), STAT-6 and STAT-5 (5,6). P100 is also known to interact with 
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the components of the U5 small nuclear ribonucleoprotein to assist in pre-mRNA splicing 
and spliceosome assembly (7). TSN1 is also involved in stress tolerance in plants such as 
Arabidopsis (8).  It is able to co-localize with G3BP (a marker for formation of stress 
granules) in response to various stress stimuli and affects the aggregation efficacy of 
these stress granules (9). In mammals, formation of such stress granules is also an 
indication of various disease processes such as tumor formation in hypoxic conditions 
(10). In this regard, Tudor-SN1 has been shown to be upregulated during human colon 
cancers via post-transcriptional regulation of the adenomatous polyposis coli (APC) gene 
(11).  Knockdown of TSN1 leads to ectopic cell death and inhibits plant fertility and, 
intriguingly, this multifunctional protein is also known to be a natural substrate for 
metacaspases in the programmed cell death degradome (12).  In connection with RNAi, 
TSN1 has been found to co-fractionate with the RISC and was the first known subunit of 
the RISC to possess a recognizable (staphylococcal) nuclease domain (13). Human TSN1 
has been shown to be involved in degradation of inosine-containing pre-miRNAs, such as 
the primary transcript of human miR-142, thus providing some sort of RNA 
surveillance/quality control mechanism (14,15). Although the structural features of the 
protein suggest a preference for binding IU containing RNA, a natural substrate for TSN1 
is yet to be discovered. 
 
Such multifunctional capabilities of TSN1 can be attributed to its complex domain 
architecture. Tudor-SN1 is composed of four tandem repeats of staphylococcal nuclease-
like domains (SN1-4) adjoining a Tudor domain fused to a C-terminal partial SN5 
domain, to form an extended TSN domain (2,16).  The SN domains possess dsRNA-
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binding capabilities (2), and mediate interactions with STAT6 (Signal Transducer and 
Activator of Transcription 6) and RNA Pol II (17). The Tudor domain consists of a 
barrel-like fold and is a protein-protein interaction domain (16). These motifs are 
abundant in various proteins and have been shown to interact with 
symmetricaldimethylated arginines (sDMAs) such as those in the C-termini of Sm 
proteins partaking in snRNPs biogenesis (18,19). Interestingly, the Tudor domains of 
several proteins are found to interact with sDMAs containing PIWI proteins (closely 
related to Argonautes) and participate in the piRNA pathway (20). Our findings in 
Chlamydomonas reinhardtii suggest that the TSN1 protein is important for RNAi, as has 
been demonstrated in other eukaryotes, and most importantly, TSN1 deletion results in 
depletion of the endogenous miRNA pool. However, addressing its specific molecular 
role will require further investigation. 
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MATERIALS AND METHODS 
 
Culture Conditions, Transformation, Selection of transgenic strains & Spot Tests 
 
Unless otherwise noted, C. reinhardtii cells were grown on Tris-Acetate-Phosphate 
(TAP) medium at 21°C under moderate light conditions (21). For generation of 
transgenic strains, transformation was carried out by introduction of linearized plasmid 
DNA into Chlamydomonas cells by the glass beads procedure (22). The Maa7-IR44s 
strain was generated from the wild-type CC-124 background by transformation of a Ble 
transgene construct (with the MAA7 IR sequence in its 3’ UTR) as previously described 
(1). For generation of the RNAi-defective mutants –Mut13-2 and Mut20- via random 
mutagenesis, the strain Maa7-IR44s was transformed with a plasmid construct imparting 
resistance to paromomycin (23). The complemented strains, mut13-2-8c, mut13-2-13c, 
mut20-133c and mut20-167c were generated by transformation of Mut13-2 and Mut20, 
respectively, with a plasmid construct containing the full-length coding sequence of 
TSN1 (with an N-terminal FLAG-CBP-AcV5 double tag). 
 
For phenotypic analyses of the different strains, spot tests were carried out on TAP media 
containing 5-fluoroindole (5-FI). The strains CC124, Maa7-IR44s, Mut13-2, Mut20, 
mut13-2-8c, mut13-2-13c, mut20-133c and mut20-167c were grown for two days in 
liquid TAP medium. For each of the strains, ~3x106 cells were collected by 
centrifugation at 5000 rpm for 3 minutes and then resuspended in 150 !l of TAP 
medium. This volume, having a concentration of 1x105 cells in 5 !l was then serially 
 38 
diluted to the following concentrations per 5 !l – 2.5x104, 6.25x103, 1.56x103 and 
3.9x102 cells. Five !l of each of the cell dilutions were plated on solid TAP+5-FI medium 
as well as on TAP plates and allowed to grow under dim lights for 7-15 days. 
 
 
Analysis of the extent of genomic deletions in Mut13-2 & Mut20 
 
Whole cell genomic DNA was isolated (from Wild-type and mutant strains) using 
standard procedures as previously described (24). The isolated genomic DNA was used 
as template for PCR reactions with primers specific for the different domains of TSN1 
and a neighboring Ankyrin/Histone Deacetylase (HDAC) gene, to determine the extent of 
the deletions in the mutants. The PCR reactions were carried out with Taq Polymerase 
according to the conditions mentioned in Table 1.1 & Table 1.2. The PCR products were 
resolved on 1.2% agarose gels and visualized by ethidium bromide staining (1,25). Actin 
gene DNA was used as a positive control for the all of the PCR reactions with the 
following conditions – 25 cycles at 94˚C for 1 min, 50˚C for 40 sec, 72˚C for 40 sec. The 
specific primer sequences for the different domains are indicated in Tables 1.1 and 1.2. 
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Table 1.1 –List of primer sequences for TSN1 domains & the PCR conditions 
DOMAINS Forward Primer Reverse Primer PCR conditions 
SN1 domain F1 
5’ATGGCGACCGG
CTGGCTGC3’ 
R1 
5’GTCCTTGGTCC
ACAGCCCCAG3’ 
30 cycles at –  
 
94˚ C – 1 min 
62˚ C – 30 sec 
72˚ C – 2 min 
 
SN2 domain F-SN2 
 
5'GCGTGCGATGT
AACCGTGTG3' 
R-SN2 
 
5'CTCCCAACCCG
CGAAACAAC3’ 
 
 
 
30 cycles at – 
 
94˚ C – 1 min 
55˚ C – 30 sec 
72˚ C – 40 sec 
SN3 domain F-SN3 
 
5'CTCCGCAAGCG
CATCATCG3' 
R-SN3 
 
5'CGCTACACGTTC
CTCCCTCCTTG3' 
30 cycles at – 
 
94˚ C – 1 min 
55˚ C – 30 sec 
72˚ C – 40 sec 
SN4 domain f-4  
 
5'GCCCTTCAACC
TGGCACTGG3' 
r-4 
 
5'GAGCTTGCCCTC
CTTTGCTGC3' 
30 cycles at – 
 
94˚ C – 1 min 
55˚ C – 40 sec 
72˚ C – 40 sec 
Linker Region FF2 
 
5’CTGCGTTGCGT
GTTGCGTTG3’ 
RR2 
 
5’CCACCACCTGA
GAGAGAGCGAGA
G3’ 
30 cycles at – 
 
94˚ C – 30 sec 
59˚ C – 30 sec 
72˚ C – 40 sec 
TSN fused domain f'-sn5  
5'GAGGCCATCAC
AGCCATGCAG3' 
r'-sn5 
5'GGTCGCCGTAC
ACGAACATGC3' 
30 cycles at – 
 
94˚ C – 1 min 
55˚ C – 40 sec 
72˚ C – 40 sec 
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Table 1.2 –List of primer sequences for HDAC/Ankyrin domains & the PCR conditions 
Domains Forward Primer Reverse Primer PCR Conditions 
Ankyrin Repeat 1 HDAC-Fa 
 
5’GCCTGGTCAACT
TCGCGGATAG3’ 
 
HDAC-Ra 
 
5'GGCACATCCA
ACAACGCACCC
3' 
30 cycles at – 
 
94˚ C – 1 min 
 58˚ C – 40 sec 
72˚ C – 1 min 
Ankyrin Repeat 2 F-HDAC2 
5'GCGTGAGAAGTT
GGGCTGGATG3' 
R-HDAC2 
 
5'CTGAATGAGC
TGCGCCACGA3'  
 
30 cycles at – 
 
94˚ C – 1 min 
59˚ C – 40 sec 
72˚ C – 30 sec 
Ankyrin Repeat 3 HDAC-Fc 
 
5'CACCAACCACAG
AGACGGGCATC3’ 
HDAC-Rc 
 
5'CCCGCTGTCGT
TCTGTCGTCTC3' 
30 cycles at – 
 
94˚ C – 1 min 
56˚ C – 30 sec 
72˚ C – 1 min 
Arginase/ 
Deacetylase 
Superfamily 
F-HDAC4 
 
5'CCAACACCGCAC
CGTATGACC3' 
 
R-HDAC4 
 
5'GCAACAGGTT
TCACACGGCG3' 
 
30 cycles at – 
 
94˚ C – 1 min 
58˚ C – 30 sec 
72˚ C – 30 sec 
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RNA extraction & Small RNA analyses 
 
Standard protocols were used for nucleic acid isolation, gel electrophoresis and 32P -
probe labeling (24-26). Total RNA extraction was carried out with TRI reagent 
(Molecular Research Center) according to the manufacturer’s instructions. For small 
RNA analyses, the isolated total RNA was resolved on 15% polyacrylamide (29:1)/ 7 M 
Urea gels and electroblotted onto Hybond-XL membranes (GE Healthcare) (1,27) at 0.9 
Amps for 2 hours. Transferred small RNAs were UV-crosslinked to the nylon membrane 
(25). For detection of specific miRNAs, these blots were then hybridized with 
complementary DNA oligonucleotides labeled at the 5’ termini with !-32P using T4 
Polynucleotide Kinase (New England Biolabs). Hybridization was carried out at 40˚C for 
72 hours using the High Efficiency Hybridization System – HS114 (Molecular Research 
Center). As a loading control, the nylon membranes were probed for U6 snRNAs using 
an "-32P -labeled U6 probe and the hybridization was carried out at 65˚C for 24 hours 
(28). For analyses of the Maa7 siRNAs, total RNA was resolved on a 15% 
polyacrylamide (29:1)/ 7M Urea/ MOPS gel and electroblotted onto a Hybond-NX 
membrane (GE Healthcare) (26). The blots were then chemically crosslinked using EDC 
(26) and a specific "-32P labeled Maa7 probe was used to detect the corresponding 
siRNAs. The 32P radioactivity signal from the blots was detected with a Phosphorimager 
(Molecular Dynamics, Sunnyvale, CA) and images were quantified using the Quantity 
One software (BioRad). 
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Plasmid Construction 
 
The TSN1 gene (512365; au5.g2631_t1) is located on chromosome 11 in the 
Chlamydomonas genome and consists of 27 exons (http://genome.jgi-
psf.org/Chlre4/Chlre4.home.html). The TRI reagent-isolated RNA was treated with 
DNase-I (Ambion, TX, USA) for 30 min at 37˚C to remove contaminating DNA. The 
DNase-I treated RNA was subsequently used for first strand cDNA synthesis with 
SuperScript II reverse transcriptase (Invitrogen) using gene-specific primers and reaction 
conditions as previously described (29). Three fragments of the full length TSN1 cDNA 
were amplified from the synthesized cDNA template using TaKaRa LA TaqTM 
Polymerase (Takara Bio Inc.) with the primer sequences & PCR conditions described in 
Table 2. 
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Table 2.0 –List of primer sequences for full-length TSN1 coding sequence & the PCR 
conditions 
Fragme
nts 
Forward Primer Reverse Primer PCR conditions 
Fragme
nt 1 
TSN-F1’ 
 
5’CGGTCATGAGCGACC
GGCTGGCT3’ 
TSN-R2’ 
 
5’CTGACCACCTCCACC
ACCTTGC3’ 
26 cycles at – 
 
94˚ C – 30 sec 
60˚ C – 30 sec 
72˚ C – 2 min 
Fragme
nt 2 
TSN-F3 
 
5’GTGGAGTGGTCGCTG
AACCTGATG3’ 
TSN-R3’ 
 
5’TTAGCACCACGGAGC
CCAGGAAG3’ 
28 cycles at – 
 
94˚ C – 30 sec 
58˚ C – 30 sec 
72˚ C – 1 min 
Fragme
nt 3 
TSN-F4’ 
 
5’GTTTGCGGAGGAGGC
GTTTGC3’ 
TSN-R4’ 
 
5’CAGGATATCCTACCG
CCGCACG3’ 
28 cycles at – 
 
94˚ C – 30 sec 
57˚ C – 30 sec 
72˚ C- 2 min 
 
The PCR products were resolved on 1.2% agarose gels and visualized by ethidium 
bromide staining (25). Each of these amplified fragments was cloned into the pSTBlue-1 
vector (Novagen), according to standard procedures (25), and the insert sequenced using 
SP6 and T7 primers. The three correct fragments were then spliced together using 
overlapping restriction sites (Fig. 2-2A) to generate the full length TSN1 coding 
sequence. The full length TSN1 fragment was finally excised from the pSTBlue-1 vector 
and cloned into a Chlamydomonas expression vector containing an N-terminal FLAG-
CBP-AcV5 double tag under the control of Hsp70a and psaD (photosystem I component) 
promoter and terminator. The insert was verified to be in-frame with the epitope tag by 
sequencing using psaD promoter/terminator primers.  
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Immunoblot Analyses 
 
Standard protocols were used for immunoblot analyses (1). In order to detect the AcV5-
tagged TSN1 protein, cells were grown to logarithmic phase and approximately 5x106 
cells were pelleted by centrifugation (13,000 g for 3 minutes) and resuspended in 50 !l of 
SDS-gel sample loading buffer (25). The samples were boiled for 5 minutes and 10 !l 
aliquots were resolved via 8% SDS-PAGE and electroblotted onto nitrocellulose 
membranes (25). For immunodetection of the AcV5-tagged TSN1 protein, the membrane 
was incubated overnight at 4˚C in a 1:10000 dilution of a mouse raised anti-AcV5 
antibody (eBioscience 14-6995). Post-incubation, the membrane was incubated for 2 
hours at room temperature in a 1:30000 dilution of a rabbit anti-mouse secondary 
antibody, conjugated to horseradish peroxidase (HRP).  For autoradiographic detection, a 
chemiluminescent substrate (ImmobilonTM, Millipore) was used. For immunodetection of 
the tryptophan synthase ß (TSß) protein, an anti-TSß antibody (polyclonal raised in 
rabbits), kindly provided by Thomas McKnight, was used at a dilution of 1:10000. 
Membranes were incubated overnight at 4˚C and then treated at room temperature for 2 
hours, with a 1:30000 dilution of a goat anti-rabbit secondary antibody conjugated to 
HRP before being used for autoradiographic detection. For immunodetection of 
Argonaute 3 (AGO3) protein levels in the different strains, a 8% SDS-PAGE gel was 
used to fractionate samples as before and the membranes with electroblotted proteins 
were incubated overnight at 4˚C with a 1:15000 dilution of a rabbit antibody raised 
against the C-terminal peptide of AGO3 conjugated to KLH (CASRSGRGAGAAEGG; 
GenScript). The membrane was incubated (for 2 hours at room temperature) with a 
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1:15000 dilution of a goat anti-rabbit secondary antibody conjugated to HRP, before 
being used for autoradiography. To test for equivalent loading of the lanes, Coomasie 
Blue staining of equivalent SDS-PAGE gels as well as immunoblotting with a polyclonal 
anti-histone H3 antibody (AbCam Cambridge, MA, USA ab1791) were used. 
 
 
Detection of epitope-tagged TSN1 protein by Immunofluorescence Microscopy 
 
For elucidation of the sub-cellular localization of the epitope-tagged TSN1 protein in the 
complemented strains, immunofluorescence microscopy was carried out using a 
modification of the protocol already described by Sanders and Salisbury (30). Cells were 
inoculated from TAP plates into 5 ml of liquid TAP media and grown for 48 hours.  Cell 
density was determined with a hemocytometer and ~4x105 cells were sub-cultured into 
another 4 ml of TAP media for 48 hours. The mutant strains – Mut13-2 and Mut20 – 
were used as negative controls. The following steps were undertaken for preparation of 
slides, fixing of cells and subsequent antibody treatment before the slides were ready for 
imaging with a fluorescence microscope. 
 
i. Slide Preparation: 
Microscope slides were cleaned as described earlier (30) with Alconox detergent and 
after rinsing with ddH2O, soaked in 5 mM ethylenediaminetetraacetic acid (EDTA) 
for 10 minutes, rinsed off with ddH2O and allowed to air dry.  A small area of the 
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slide was coated with freshly made 0.1% polyethyleneimine (PELI) solution, 
incubated for 1 minute and then rinsed off with ddH2O and allowed to air-dry. 
ii. Fixing cells to prepared slides: 
Approximately 200 !l of cells from the culture in mid-logarithmic phase were placed 
onto the PELI coated area of the slide. The culture was allowed to settle for 15 
minutes and then excess cells were drained off. Cells were fixed by covering the slide 
with 4% Paraformaldehyde in 1X Phosphate Buffered Saline (PBS) for 30 minutes. 
The paraformaldehyde solution was drained off immediately afterwards and the slide 
was washed with methanol. Fixation was continued by soaking the slide two times for 
10 minutes each in methanol that was pre-chilled to –20˚C.  
iii. Cell Rehydration: 
Cells were rehydrated by washing/soaking the slides in 1X PBS for 15 minutes and 
then incubated with 1X PBS containing 0.05% Triton-X for 10 minutes. Washing was 
carried out twice again for 15 minutes in 1X PBS. 
iv. Blocking Buffer & Antibody/ DAPI treatments: 
The cells were covered with blocking buffer (see composition below), and incubated for 
2 hours in a humidity chamber (Sigma H6644) and then excess buffer was drained off. 
Cells were covered with blocking buffer containing primary antibody (affinity purified 
monoclonal mouse anti-baculovirus envelope gp64 protein – Anti-AcV5, eBioscience 14-
6995) at a 1:10000 dilution and incubated overnight in the humidity chamber at 4˚C. 
Slides were then soaked 3 times for 15 minutes each in 1X PBS. Excess primary antibody 
solution was drained off. Next, blocking buffer containing secondary antibody (Alexa 
Fluor 488 conjugated goat anti-mouse, Invitrogen A11001) at a 1:500 dilution was used 
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to cover the slides and incubated for 2 hours in the humidity chamber. Cells were next 
covered with a 5 !M 4',6-diamidino-2-phenylindole (DAPI) solution and incubated for 
20 minutes at room temperature in the dark. The slides were then soaked 3 times for 15 
minutes each in 1X PBS and allowed to air-dry. Coverslips were mounted over the cells 
using GEL-MOUNT (Electron Microscopy Sciences 17985-10). 
v. Microscopy: 
Cells treated in the above manner were observed and imaged using an Olympus Flouview 
500 Laser Scanning Fluorescence Microscope with Olympus BX60 software version 4.3. 
DAPI was excited with a 405 nm diode laser and was detected between 430-480 nm. The 
Alexa Fluor 488 was excited with a 488 nm laser and detected between 505-525 nm. The 
phase contrast images were obtained using the collection of transmitted light with a 633 
nm laser. Image processing and pseudocoloring were done using ImageJ (National 
Institutes of Health, Bethesda, Maryland, USA). 
Solutions: 
• 0.1% PELI – 10 !l polyethyleneimine (Sigma, P3143) dissolved in ddH2O to 
a final volume of 10 ml 
• Blocking Buffer – 10 mM KH2PO4 pH 7.2, 10 mM K2HPO4 pH 7.2, 5% 
Glycerol, 5% Normal Goat Serum (BioSource PCN5000), 1% Cold Water 
Fish Gelatin (Sigma G7765), 1% Bovine Serum Albumin and 0.04% Sodium 
Azide 
• 5!M DAPI solution – 5 !l of 1 mg/ml DAPI (Sigma D9542) stock diluted in 
1 ml ddH2O 
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Immunoprecipitation of epitope tagged-TSN1 
 
In order to purify the FLAG-tagged TSN1 protein being expressed in the complemented 
strains –mut13-2-8c and mut13-2-13c- the transgenic strains were grown to 
midlogarithmic phase in TAP medium containing 7.5 !M 5-FI and harvested by 
centrifugation at 5000 rpm for 10 minutes. The Flag-Ble13 strain was used as a 
purification control. This transgenic strain contains a dominant selectable marker (Ble 
transgene) conferring resistance to the Bleomycin antibiotic. The Ble protein contains a 
FLAG-CBP-AcV5 tag and expresses as a ~19 kDa fusion protein. For each 
immunoprecipitation experiment, ~ 5x109 cells were resuspended in lysis buffer [20 mM 
Tris-HCL (pH 7.5), 150 mM NaCl, 0.1 mM EDTA, 5 mM Mg-Acetate, 2.0 mM CaCl2, 
10% glycerol] containing 2.0 mM Benzamidine, 0.2 mM PMSF, 5µl/ml plant protease 
inhibitor (Sigma). Cells were broken by two passages through a French-press at 5000 psi. 
An aliquot of the total lysate was stored (at -20˚C) for SDS-PAGE and immunoblot 
analyses. The lysate was centrifuged at 16000 g for 30 minutes at 4˚C and the supernatant 
(Fraction S16) was centrifuged again at 100000 g for 90 minutes at 4˚C to separate out 
soluble proteins (Fraction S100). The supernatant was incubated with ANTI-FLAG (M2) 
beads (Sigma A2220) overnight at 4˚C. After overnight incubation, the beads were 
collected by centrifugation (~1500 g for 5 minutes) and before proceeding to the washing 
steps an unbound fraction was also collected (Unbound protein fraction) from the bead 
supernatant.  The beads were then washed with the following buffers for 15 minutes 
(each wash) at 4˚C: 
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Three washes with Washing Buffer A (20 mM Tris-HCL (pH 7.5), 300 mM NaCl, 0.1 
mM EDTA, 2 mM Mg-Acetate, 2 mM CaCl2, 10% glycerol) and two washes with 
Washing Buffer B (20 mM Tris-HCL (pH 7.5), 150 mM NaCl, 2 mM Mg-Acetate, 2 mM 
CaCl2, 10% glycerol). Both wash buffers were supplemented with 2.0 mM Benzamidine, 
0.2 mM PMSF, 5µl/ml plant protease inhibitor (Sigma) and 0.1% Triton X-100. Aliquots 
of the first (Wash 1) and the last wash (Wash 2) were stored to be used for SDS-PAGE 
and immunoblot analyses. The beads were resuspended in 2X SDS sample loading buffer 
(25) and the eluted proteins were resolved on a 8% SDS-PAGE gel (for FLAG-AcV5-
tagged TSN1 detection) or a 15% SDS-PAGE gel (for AcV5-Flag-Ble detection as a 
control for non-specific association of proteins with the beads). The other fractions 
collected during the purification process were also separated by SDS-PAGE and 
subjected to immunoblot analyses with an anti-AcV5 antibody.  AGO3 primary antibody 
was used, as described before, in immunoblotting analyses to ascertain the presence of 
this protein in the FLAG purified TSN1 complex. 
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RESULTS 
 
Mut20 shows a larger genomic deletion compared to Mut13-2 
 
Genomic DNA isolated from the wild-type CC-124 and the mutant strains –Mut13-2 and 
Mut20- was used for PCR amplification of specific domains of the TSN1 gene and the 
neighboring Histone Deacetylase (HDAC) gene containing Ankyrin repeats at its 5’-
terminus (Figure 2-1A).  The TSN1 gene (512365; au5.g2631_t1) consists of four 
staphylococcal domains (SN1-4), which are joined to a fused (Tudor-SN5) TSN domain 
via a short linker region. The SN1 domain was not detected in the PCR amplifications 
using as template Mut20 genomic DNA, while the region was amplified in the case of 
Mut13-2.  The SN2-4 domains as well as the linker region and the fused TSN domain 
were not detected in the PCR amplifications from both Mut13-2 and Mut20 (Figure 2-
1C), while all the expected PCR fragments were obtained when using as template DNA 
from the wild-type CC-124 (used as a positive control).  
 
To determine the extent of the genomic deletion in both mutants, the DNA from both 
strains was also used for amplifying the specific domains of the neighboring Histone 
Deacetylase gene (512363, au5.g2630_t1). The Ankyrin repeats 1 and 2 on the 5’-
terminus of the gene were detected in the PCR amplifications from both Mut13-2 and 
Mut20 (Figure 2-1B), but Ankyrin repeat 3 was found to be missing in Mut20 while still 
present in Mut13-2. Both mutants were found to lack the Arginase/Deacetylase domain, 
while all the motifs tested were successfully amplified in the wild-type CC-124. 
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Amplification of the Actin1 gene was used to assess the quality of the genomic DNA 
isolated from the respective strains (Figure 2-1B and C). 
 
Taken together, the data suggests that Mut20 has a larger genomic deletion when 
compared to Mut13-2, including complete deletion of the TSN1 gene. In contrast, Mut13-
2 may still express a truncated version of the TSN1 gene including at least the SN1 
domain. The neighboring gene HDAC is also partly deleted in both mutants and it may be 
relevant for further characterization of the mutants and their RNAi defect. However, 
considering the fact, that TSN1 has been implicated in RNAi and RISC association in 
metazoans (2,13), we have aimed towards complementing TSN1 function in our mutants, 
to investigate whether this would reconstitute the RNAi phenotype. 
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Figure 2-1. Genomic Deletions in the RNAi-defective mutants –Mut13-2 & Mut20 
(A) Deletions generated by random insertional mutagenesis in the two mutants are shown 
in a genomic context in the JGI genome browser*. (B) The Hdac/Ankyrin gene consisting 
of three ankyrin domains and one arginase/deacetylase domain. The figure illustrates that 
both mutants are missing the arginase/deacetylase domain while ankyrin 1 and ankyrin 2 
domains are present in both. Ankyrin 3 domain is present in Mut13-2 while it is absent in 
Mut20. (C) The TSN1 gene consists of four SN domains linked to a fused TSN domain 
(SN5-Tudor). In case of Mut20 the full length TSN1 gene is found to be missing, while in 
Mut13-2 the SN1 domain still appears to be present. 
 
The wild-type strain (CC-124) was used as a positive control. Amplification of the Actin1 
gene was also carried out to test the quality of the genomic DNA template from all 
strains. The color-coded domains in (A) are the same as indicated in (B) and (C).  
*(http://genome.jgi-psf.org/cgi-
bin/browserLoad/?db=Chlre4&position=chromosome_11:1794646-1834952). 
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Complementation of Mut13-2 & Mut20 with epitope-tagged TSN1 
 
In order to assemble the full-length length TSN1 coding sequence, three different 
fragments (I ~1.2 kb, II ~0.9 kb, III ~1.2 kb) of the TSN1 gene were amplified from the 
cDNA obtained by reverse-transcription of total RNA, purified from the strain Maa7-IR-
44s (data not shown). The construct was cloned into a Chlamydomonas expression vector 
(NE689) under the regulatory control of Hsp70a and PsaD (Photosystem I component) 
dual promoter sequences to achieve constitutive expression of the insert (Figure 2-2A). 
Using the glass beads procedure (22), the epitope-tagged TSN1 construct was introduced 
into the Mut13-2 and Mut20 strains to achieve stable nuclear transformation. 
Transformants were initially screened by plating on 10 !M 5-FI TAP media, for recovery 
of the RNAi phenotype, and subsequently via immunoblot analyses to detect the 
expression of AcV5-tagged TSN1. The levels of tryptophan synthase ß-subunit protein 
(TSß) in selected strains were also ascertained by immunoblotting (Figure 2-2B). The 
Maa7-IR44s strain is RNAi activated and acts via the translational repression of the TSß 
protein (unpublished data). The mutant strains (Mut13-2 and Mut20) showed higher 
levels of TSß than that of the Maa7-IR44s strain indicating a defect in RNAi. Hence, as 
suggested from early studies in metazoans (13), it seems that TSN1 function is also 
essential for RNAi activity in Chlamydomonas reinhardtii.  
 
In the case of the Mut13-2 transformants, mut13-2-8c and mut13-2-13c showed good 
levels of expression of the epitope-tagged TSN1 construct. The TSß levels for the 
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transformants were found to be lower than that of Mut13-2 and closer to that of Maa7-
IR44s (Figure 2-2B). For phenotypic analyses, the indicated strains (Figure 2-2C) were 
serially diluted and cells were spotted on 10 !M 5-FI TAP medium. The growth pattern 
of spotted cells was inversely correlated with the TSß levels for the examined strains. The 
mutants as well as the wild-type CC-124 failed to grow on 5-FI while the Maa7-IR-44s 
strain and the Mut13-2 complemented strains showed comparable growth. This indicates 
that expression of the epitope-tagged TSN1 construct successfully reverted the RNAi-
defective phenotype in Mut13-2. 
  
Two Mut20 transformants –mut20-133c and mut20-167c- were chosen for further 
analyses after screening for transformants with appropriate levels of expression of the 
AcV5-tagged TSN1 protein via immunoblotting. The TSß protein levels for the Mut20 
transformants -mut20-133c and mut20-167c- were a bit lower than that of Mut20 
although not as low as the Maa7-IR-44s strain (Figure 2-2D). This expression analysis 
was also supported by spot test assays on 10 !M 5-FI TAP, where the wild-type CC-124 
and the Mut20 strain died or grew poorly. In contrast, the Mut20 transformants did show 
some degree of survival of 5-FI, but did not grow as well as the Maa7-IR-44s strain 
(Figure 2-2E). This suggested that the RNAi phenotype was only partially 
complemented, at best, in the Mut20 complemented strains. 
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Figure 2-2. Complementation of RNAi-defective mutants with epitope-tagged TSN1 
(A) The full-length TSN1 coding sequence was cloned into a Chlamydomonas expression 
vector (NE689) that contains an N-terminal FLAG-CBP-AcV5 tag. The TSN1-NE689 
construct was used to transform Mut13-2 and Mut20 using the glass beads procedure 
(22). (B) Immunoblot analyses for detection of the AcV5-tagged TSN1 protein in the 
Mut13-2 complemented strains. A separate Coomasie-stained gel was used as a loading 
control. Anti-TSß antibody was used to detect the levels of the tryptophan synthase ß-
subunit protein in the indicated strains. Detection of histone H3 was used as a loading 
control. (C) Phenotypic analyses – growth and survival on TAP medium and TAP 
containing 10 !M 5-FI for wild-type CC-124, Maa7-IR-44s, Mut13-2, Mut20 and two 
Mut13-2 complemented strains –mut13-2-8c and mut13-2-13c. 
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Figure 2-2 (continued). Complementation of RNAi-defective mutants with epitope-
tagged TSN1 – (D) Immunoblot analyses for AcV5-tagged TSN1 shows that mut20-
133c and mut20-167c express appropriate levels of tagged-TSN1 protein. Histone H3 
was used as a loading control. TSß protein levels were also detected by immunoblotting 
in the indicated strains. The two Mut20 complemented strains showed lower levels of 
TSß in comparison with the mutant. An equivalent, Coomasie-stained, gel was used as 
loading control. (E) Phenotypic analyses – growth and survival on TAP and TAP 
medium containing 10 !M 5-FI. The wild type CC-124 and Mut20 died on 5-FI plates 
whereas the complemented strains –mut20-133c and mut20-167c- showed poor growth 
on 5-FI containing medium. Hence, the RNAi phenotype seems only partially restored in 
the Mut20 complemented strains. 
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MicroRNA & Maa7 small interfering RNA levels  
in Mut13-2 and Mut20 
 
In order to investigate the levels of endogenous miRNAs in Mut13-2, Mut20 as well as in 
the complemented strains, total RNA isolated using TRI reagent was resolved on a 
denaturing polyacrylamide gel, using standard protocols (27), and subsequently probed 
for small RNAs using 32P-labeled oligonucleotides. We probed for two species of 
endogenous miRNAs –miR248 and miR2726. In the case of Mut13-2, the miRNA levels 
did not seem to vary much as compared to the Maa7-IR44s strain, whereas Mut20 
showed significant reduction in the amounts of miR248 and miR2726 (Figure 2-3A).  
 
For the Mut13-2 complemented strain, mut13-2-8c displayed somewhat elevated levels 
of miRNAs whereas mut13-2-13c did not show an appreciable change in miRNA 
amounts (Figure 2-3A). In contrast, the Mut20 complemented strains showed only a very 
minor, if at all, increase in endogenous miRNAs levels (Figure 2-3B). The AGO3 
protein, which is an integral component of the core RNAi machinery in Chlamydomonas 
(31), correlated in abundance with those of the endogenous miRNAs (Figure 2-3C). This 
indicated that in the case of the Mut20 transformants there is, at best, partial 
complementation of the RNAi defect. We also examined the Maa7 siRNAs, which were 
depleted in Mut20 in comparison with the parental strain Maa7-IR44s (Figure 2-3D). In 
contrast, Mut13-2 only showed a partial reduction of Maa7 siRNAs amounts. The mut13-
2-8c strain showed a clear increase in Maa7 siRNA levels, thus indicating successful 
complementation of the Mut13-2 mutant. For the Mut20 complemented strains, however, 
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the Maa7siRNAs did not revert back to Maa7-IR44s levels, further confirming that the 
RNAi machinery is not fully recovered in these transformants.  
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Figure 2-3. Endogenous miRNAs and Maa7 siRNAs in Mut13-2 & Mut20 - (A) 
Northern blotting for detection of miR248 and miR2726 in the indicated strains, using 
radiolabeled anti-miR248 & anti-miR2726 oligonucleotides. Wild type and Maa7-IR44s 
showed standard levels of the examined miRNAs. The miRNA pool was depleted in 
Mut20 whereas the change in Mut13-2 was not as significant. The Mut13-2 
complemented strains did not show appreciable change in miRNA levels as well. 
Hybridization to the U6 snRNA was used as control for equivalent loading of all lanes. 
(B) Northern blotting for miR248 and miR2726 in the Mut20 complemented strains. U6 
snRNA hybridization was used to assess equivalent loading of the lanes. 
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Figure 2-3. (continued)– (C) Immunoblotting analyses for detection of the AGO3 
protein (an essential component of the core RNAi machinery in Chlamydomonas) in Wild 
type, Maa7-IR44s, Mut20, mut20-133c and mut20-167c strains. Detection of histone H3 
was used as a loading control. (D) Northern blot analyses for detection of Maa7 siRNAs. 
The RNAi activated strain – Maa7-IR44s- showed, as expected, the highest level of 
Maa7siRNAs. U6 snRNA hybridization was used to detect equivalent loading of all 
lanes. 
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Subcellular localization of TSN1 in Chlamydomonas reinhardtii 
 
The subcellular localization of a particular protein is to a certain extent suggestive of its 
function within a cell. This is especially important considering the fact that the RNAi 
pathway is highly compartmentalized into distinctive nuclear and cytoplasmic phases 
(32). To investigate the subcellular localization of the TSN1 protein in Chlamydomonas 
reinhardtii, we utilized an Alexa Fluor 488 secondary antibody to detect by fluorescence 
microscopy the N-terminal AcV5 tag of TSN1. The mut13-2-13c and mut20-167c 
transformants showed appreciable levels of expression of the tagged protein (Figure 2-3) 
and were selected for these experiments. The respective mutants –Mut13-2 and Mut20- 
were used as negative controls and revealed that there was no detectable cross-reactivity 
of either the primary or secondary antibodies with non-specific proteins in the fixed cells 
(Figure 2-4B and D). 
 
In both transformed strains, there was a detectable Alexa Fluor 488 signal indicative of 
the presence of the AcV5-tagged TSN1 protein (Figure 2-4A and C). DAPI staining 
revealed the localization of the nuclear DNA as well as the plastid DNA nucleoids. The 
Alexa Fluor 488 signal for the mut13-2-13c strain showed a diffused distribution over the 
cells, suggesting dual localization of the TSN1 protein in the cytoplasm as well as in the 
nucleus. The mut20-167c strain showed greater specificity of the Alexa Fluor 488 signal 
concentrated mostly in the cytoplasm, although fluorescence was also visible in a 
perinuclear fashion (Figure 2-4C).  
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Approximately 110 cells from the mut20-167c images were examined individually to 
assess the preferential localization of the AcV5-tagged TSN1 protein (Figure 2-4E). Of 
the counted cells, 63% showed only cytoplasmic localization whereas 32% had both 
cytoplasmic and nuclear signals. These results seem to suggest a predominant 
cytoplasmic localization of the AcV5-tagged TSN1 protein, which supports its 
association with the RISC in the cytosol as revealed from other studies in metazoans (13). 
However, a dual nucleo-cytoplasmic localization could not be ruled out as seen with the 
perinuclear signals and the overlap with the DAPI stained nucleus. This provides support 
for the multifunctional nature of the TSN1 protein, which has also been revealed to 
partially localize to the nucleus in Arabidopsis thaliana (2,8).  
 
 
 
 
 
 
 
 63 
DAPI AlexaFluor488 Merge Phase 
mut13-2-13c complemented strain  
DAPI AlexaFluor488 Merge Phase 
Mut13-2 
!"#
$"#
 
 
 
 
Figure 2-4. Immunofluorescence detection of epitope-tagged TSN1 – (A) The Mut13-
2 complemented strain –mut13-2-13c- expressing the AcV5-tagged TSN1 protein was 
used to ascertain the subcellular localization of TSN1.  The arrow points to the green 
signal indicating the TSN1 localization (B) Mut13-2 was used as a negative control for 
the experiments. No significant signal was detected for Alexa-Fluor 488. From left to 
right: DAPI staining (blue) of DNA, Alexa Fluor 488 bound to anti-AcV5 (green), 
merged image of DAPI and Alexa Fluor 488 signals and phase contrast image. 
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Figure 2-4 (continued). Immunofluorescence detection of AcV5-tagged TSN1 – (C) 
Mut20 complemented strain –mut20-167c- used to visualize the subcellular localization 
of tagged TSN1. The signal was mostly localized in the cytoplasm although some 
perinuclear localization was also detected. (D) Mut20 was used as a negative control. No 
obvious signal was detected for Alexa Fluor 488. From left to right: DAPI staining (blue) 
of DNA, Alexa Fluor 488 bound to anti-AcV5 (green), merged image of DAPI and Alexa 
Fluor 488 signals and phase contrast image. (E) Approximately 110 cells (mut20-167c) 
were individually examined for the subcellular localization of AcV5-tagged TSN1. The 
detected signal was mostly cytoplasmic although a number of cells showed both nuclear 
and cytoplasmic localization. 
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Co-Immunoprecipitation of AcV5-tagged TSN1 
 
TSN1 has been shown to be a component of the RISC complex in Drosophila, C. elegans 
as well as in mammals (13,14) and this is consistent with our sub-cellular localization 
studies in Chlamydomonas reinhardtii. In Drosophila, a Tudor domain-containing 
protein –Tud- has been shown to interact with the PIWI protein AGO3 (33). Considering 
these facts we wanted to investigate whether TSN1, which is also a Tudor-domain 
containing protein, is capable of interacting with the Argonaute AGO3 in 
Chlamydomonas reinhardtii. The complemented strains –mut13-2-8c, mut13-2-13c- were 
used to affinity purify the epitope-tagged TSN1 protein using FLAG beads based on a 
previously described protocol (34). The Flag-Ble13 strain was used as a purification 
control for non-specific association of proteins with the FLAG beads. From each step of 
the purification process the following fractions (as described under Materials and 
Methods) were collected: Total Cell, Total Lysate, Fraction S16, Fraction S100, Unbound 
proteins, Wash 1 and Wash 2. These fractions along with the proteins associated with the 
FLAG beads were resolved by SDS-PAGE, and the AcV5-tagged TSN1 and AGO3 
proteins were detected by immunoblotting using standard protocols. 
 
The Mut13-2 complemented strain -mut13-2-13c- expressed adequate levels of the 
AcV5-tagged TSN1 that was retained on the FLAG beads (Figure 2-5 A). However, we 
could not detect association of AGO3 with FLAG beads bound TSN1 (Figure 2-5A and 
B). The other Mut13-2 complement –mut13-2-8c- also expresses an appropriate level of 
the epitope-tagged TSN1 protein (Figure 2-5C) and shows a fully restored RNAi (Figure 
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2-3). However, although the AGO3 protein was detected in several fractions collected 
during purification, it failed to associate with TSN1 retained on the FLAG beads (Figure 
2-5D). These results suggest that TSN1 does not seem to interact with Chlamydomonas 
AGO3 at high affinity, although both proteins are associated with the RISC holo-enzyme 
in metazoans (13,14,31). 
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Figure 2-5. Immunoprecipitation of AcV5-tagged TSN1 – (A) Immunoblot analyses 
for detection of the TSN1 protein, affinity purified on FLAG beads. The Mut13-2 
complemented strain –mut13-2-13c- was used for FLAG beads affinity purification. (B) 
Immunoblot analyses for the detection of the AGO3 protein in the various fractions of the 
indicated strain. AGO3 (~120 kDa) was detectable in mut13-2-13c but does not show 
association with the FLAG-beads.  
 
The fractions collected at various steps of purification (methods section) were used for 
immunodetection of the tagged protein as well as for detection of AGO3. Flag-Ble13 was 
used as a purification control. The Ble13 strain contains a dominant selectable marker 
conferring resistance to the Bleomycin antibiotic. The Ble protein contains a FLAG-CBP-
AcV5 tag and expresses a ~19 kDa fusion protein. 
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Figure 2-5 (continued). Immunoprecipitation of AcV5-tagged TSN1 – (C) 
Immunoblot analyses for the detection of FLAG affinity purified TSN1 protein in the 
mut13-2-8c complemented strain. (D) Immunoblot analyses for the detection of the 
AGO3 protein in the various fractions obtained during the purification of tagged TSN1 
from mut13-2-8c. Although AGO3 (~120 kDa) was detected in the indicated fractions, it 
does not seem to interact with TSN1 retained on the FLAG beads. 
 
 
 
 
 
 
 70 
Literature Cited 
 
1. Rohr, J., Sarkar, N., Balenger, S., Jeong, B.R. and Cerutti, H. (2004) Tandem 
inverted repeat system for selection of effective transgenic RNAi strains in 
Chlamydomonas. Plant J, 40, 611-621. 
2. Li, C.L., Yang, W.Z., Chen, Y.P. and Yuan, H.S. (2008) Structural and functional 
insights into human Tudor-SN, a key component linking RNA interference and 
editing. Nucleic Acids Res, 36, 3579-3589. 
3. Tong, X., Drapkin, R., Yalamanchili, R., Mosialos, G. and Kieff, E. (1995) The 
Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel 
cellular coactivator that can interact with TFIIE. Mol Cell Biol, 15, 4735-4744. 
4. Leverson, J.D., Koskinen, P.J., Orrico, F.C., Rainio, E.M., Jalkanen, K.J., Dash, 
A.B., Eisenman, R.N. and Ness, S.A. (1998) Pim-1 kinase and p100 cooperate to 
enhance c-Myb activity. Mol Cell, 2, 417-425. 
5. Valineva, T., Yang, J. and Silvennoinen, O. (2006) Characterization of RNA 
helicase A as component of STAT6-dependent enhanceosome. Nucleic Acids Res, 
34, 3938-3946. 
6. Paukku, K., Yang, J. and Silvennoinen, O. (2003) Tudor and nuclease-like 
domains containing protein p100 function as coactivators for signal transducer 
and activator of transcription 5. Mol Endocrinol, 17, 1805-1814. 
7. Yang, J., Valineva, T., Hong, J., Bu, T., Yao, Z., Jensen, O.N., Frilander, M.J. and 
Silvennoinen, O. (2007) Transcriptional co-activator protein p100 interacts with 
snRNP proteins and facilitates the assembly of the spliceosome. Nucleic Acids 
Res, 35, 4485-4494. 
8. dit Frey, N.F., Muller, P., Jammes, F., Kizis, D., Leung, J., Perrot-Rechenmann, 
C. and Bianchi, M.W. (2010) The RNA binding protein Tudor-SN is essential for 
stress tolerance and stabilizes levels of stress-responsive mRNAs encoding 
secreted proteins in Arabidopsis. Plant Cell, 22, 1575-1591. 
9. Gao, X., Ge, L., Shao, J., Su, C., Zhao, H., Saarikettu, J., Yao, X., Yao, Z., 
Silvennoinen, O. and Yang, J. (2010) Tudor-SN interacts with and co-localizes 
with G3BP in stress granules under stress conditions. FEBS Lett, 584, 3525-3532. 
10. Moeller, B.J., Cao, Y., Li, C.Y. and Dewhirst, M.W. (2004) Radiation activates 
HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free 
radicals, and stress granules. Cancer Cell, 5, 429-441. 
11. Tsuchiya, N., Ochiai, M., Nakashima, K., Ubagai, T., Sugimura, T. and 
Nakagama, H. (2007) SND1, a component of RNA-induced silencing complex, is 
up-regulated in human colon cancers and implicated in early stage colon 
carcinogenesis. Cancer Res, 67, 9568-9576. 
12. Sundstrom, J.F., Vaculova, A., Smertenko, A.P., Savenkov, E.I., Golovko, A., 
Minina, E., Tiwari, B.S., Rodriguez-Nieto, S., Zamyatnin, A.A., Jr., Valineva, T. 
et al. (2009) Tudor staphylococcal nuclease is an evolutionarily conserved 
component of the programmed cell death degradome. Nat Cell Biol, 11, 1347-
1354. 
 71 
13. Caudy, A.A., Ketting, R.F., Hammond, S.M., Denli, A.M., Bathoorn, A.M., Tops, 
B.B., Silva, J.M., Myers, M.M., Hannon, G.J. and Plasterk, R.H. (2003) A 
micrococcal nuclease homologue in RNAi effector complexes. Nature, 425, 411-
414. 
14. Scadden, A.D. (2005) The RISC subunit Tudor-SN binds to hyper-edited double-
stranded RNA and promotes its cleavage. Nat Struct Mol Biol, 12, 489-496. 
15. Yang, W., Chendrimada, T.P., Wang, Q., Higuchi, M., Seeburg, P.H., Shiekhattar, 
R. and Nishikura, K. (2006) Modulation of microRNA processing and expression 
through RNA editing by ADAR deaminases. Nat Struct Mol Biol, 13, 13-21. 
16. Friberg, A., Corsini, L., Mourao, A. and Sattler, M. (2009) Structure and ligand 
binding of the extended Tudor domain of D. melanogaster Tudor-SN. J Mol Biol, 
387, 921-934. 
17. Yang, J., Aittomaki, S., Pesu, M., Carter, K., Saarinen, J., Kalkkinen, N., Kieff, E. 
and Silvennoinen, O. (2002) Identification of p100 as a coactivator for STAT6 
that bridges STAT6 with RNA polymerase II. Embo J, 21, 4950-4958. 
18. Selenko, P., Sprangers, R., Stier, G., Buhler, D., Fischer, U. and Sattler, M. 
(2001) SMN tudor domain structure and its interaction with the Sm proteins. Nat 
Struct Biol, 8, 27-31. 
19. Cote, J. and Richard, S. (2005) Tudor domains bind symmetrical dimethylated 
arginines. J Biol Chem, 280, 28476-28483. 
20. Siomi, M.C., Mannen, T. and Siomi, H. (2010) How does the royal family of 
Tudor rule the PIWI-interacting RNA pathway? Genes Dev, 24, 636-646. 
21. E. H. Harris, The Chlamydomonas Sourcebook – A Comprehensive Guide to 
Biology and Laboratory Use (Academic Press, San Diego, CA, 1989).  
22. Kindle, K.L. (1990) High-frequency nuclear transformation of Chlamydomonas 
reinhardtii. Proc Natl Acad Sci U S A, 87, 1228-1232. 
23. Sizova, I., Fuhrmann, M. and Hegemann, P. (2001) A Streptomyces rimosus 
aphVIII gene coding for a new type phosphotransferase provides stable antibiotic 
resistance to Chlamydomonas reinhardtii. Gene, 277, 221-229. 
24. Cerutti, H., Johnson, A.M., Gillham, N.W. and Boynton, J.E. (1997) A eubacterial 
gene conferring spectinomycin resistance on Chlamydomonas reinhardtii: 
integration into the nuclear genome and gene expression. Genetics, 145, 97-110. 
25. Sambrook, J. and Russell, D.W. (2006) The condensed protocols from Molecular 
cloning : a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring 
Harbor, N.Y. 
26. Pall, G.S., Codony-Servat, C., Byrne, J., Ritchie, L. and Hamilton, A. (2007) 
Carbodiimide-mediated cross-linking of RNA to nylon membranes improves the 
detection of siRNA, miRNA and piRNA by northern blot. Nucleic Acids Res, 35, 
e60. 
27. Ibrahim, F., Rohr, J., Jeong, W.J., Hesson, J. and Cerutti, H. (2006) Untemplated 
oligoadenylation promotes degradation of RISC-cleaved transcripts. Science, 314, 
1893. 
28. Church, G.M. and Gilbert, W. (1984) Genomic sequencing. Proc Natl Acad Sci U 
S A, 81, 1991-1995. 
29. Carninci, P., Nishiyama, Y., Westover, A., Itoh, M., Nagaoka, S., Sasaki, N., 
Okazaki, Y., Muramatsu, M. and Hayashizaki, Y. (1998) Thermostabilization and 
 72 
thermoactivation of thermolabile enzymes by trehalose and its application for the 
synthesis of full length cDNA. Proc Natl Acad Sci U S A, 95, 520-524. 
30. Sanders, M.A. and Salisbury, J.L. (1995) Immunofluorescence microscopy of 
cilia and flagella. Methods Cell Biol, 47, 163-169. 
31. Casas-Mollano, J.A., Rohr, J., Kim, E.J., Balassa, E., van Dijk, K. and Cerutti, H. 
(2008) Diversification of the core RNA interference machinery in 
Chlamydomonas reinhardtii and the role of DCL1 in transposon silencing. 
Genetics, 179, 69-81. 
32. Ketting, R.F. (2011) The many faces of RNAi. Dev Cell, 20, 148-161. 
33. Nishida, K.M., Okada, T.N., Kawamura, T., Mituyama, T., Kawamura, Y., 
Inagaki, S., Huang, H., Chen, D., Kodama, T., Siomi, H. et al. (2009) Functional 
involvement of Tudor and dPRMT5 in the piRNA processing pathway in 
Drosophila germlines. Embo J, 28, 3820-3831. 
34. Rigaut, G., Shevchenko, A., Rutz, B., Wilm, M., Mann, M. and Seraphin, B. 
(1999) A generic protein purification method for protein complex characterization 
and proteome exploration. Nat Biotechnol, 17, 1030-1032. 
35. Burroughs, A.M., Ando, Y., de Hoon, M.L., Tomaru, Y., Suzuki, H., 
Hayashizaki, Y. and Daub, C.O. (2011) Deep-sequencing of human Argonaute-
associated small RNAs provides insight into miRNA sorting and reveals 
Argonaute association with RNA fragments of diverse origin. RNA Biol, 8, 158-
177. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 73 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3 
 
 
 
 
 
 
DISCUSSION & CONCLUSION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 74 
DISCUSSION & CONCLUSION 
 
 
 
Over the last decade the RNA interference pathway has become an important subject of 
research. It has also been widely used as a tool for understanding gene function via the 
delivery of specific RNAi triggers which are able to impart long-term and heritable gene 
silencing in various systems such as plants and mammals (1). However, a number of 
issues remain unsolved regarding the RNAi process. Mechanisms such as regulation of 
gene expression via RNAi-mediated translational repression are now beginning to be 
understood properly (2,3). The myriad properties of microRNAs in various facets of 
biological pathways and signaling networks are continually being revealed (4,5). 
Interestingly, these small RNA molecules have also been found to up-regulate 
translational processes during certain stages of the cell cycle (6). In addition, the RISC 
follows a complex and ordered assembly into an effector holo-enzyme (7). However, the 
function of a number of the component proteins of the RISC is yet to be fully understood. 
 
One such component of the RISC is Tudor-SN1 (TSN1), which has been reported to 
carry out degradation of an inosine containing miRNA precursor acting as a sort of 
quality control mechanism for faulty pre-miRNAs in metazoans (8,9). But a natural 
substrate for the protein is yet to be found. Indeed, the exact role of TSN1 in the RNAi 
pathway remains open to question. Considering the multi-functional nature of TSN1 and 
its association with the RISC it is possible that this versatile protein may have additional 
functions in RNAi besides just being a quality control mechanism (8,10,11).  
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In this study we have aimed to characterize two related mutants –Mut13-2 & Mut20– in 
Chlamydomonas reinhardtii both of which were found to be missing a number of the 
essential domains of the TSN1 gene. The extent of the genomic deletions was found to be 
larger in Mut20 when compared to Mut13-2, but both mutants showed an RNAi defect, 
based on their sensitivity to 5-FI and normal levels of the TSß protein. Interestingly, the 
Maa7 siRNAs were reduced in the case of Mut13-2 and virtually absent in Mut20. We 
also found that in Mut20 endogenous miRNAs were almost completely depleted whereas 
still detectable in Mut13-2. Hence, it can be concluded that Mut20 shows a stronger 
RNAi defective phenotype compared to Mut13-2. We reasoned that restoring TSN1 
function might recover the RNAi-defective phenotype in the Chlamydomonas mutants. 
However, transformation of Mut20 with a construct expressing epitope-tagged TSN1 did 
not seem to fully restore the RNAi activity. In contrast, we successfully achieved 
complementation of Mut13-2 with full recovery of the RNAi phenotype and Maa7 
siRNA levels. These results suggest that TSN1 is definitely important for RNAi in 
Chlamydomonas reinhardtii. 
 
An obvious issue is the need to understand the reason(s) for the differences in RNAi 
defects between Mut20 and Mut13-2 as well as for the lack of complementation of 
Mut20. In other studies, it has been shown that the N-terminal SN domains of TSN1 are 
required for RNA binding and a minimum of two tandem SN domains are required for 
this process (9). The SN1 domain of the TSN1 gene and the neighboring Ankyrin repeat 
3 domain of a neighboring Histone Deacetylase (HDAC) gene are deleted in Mut20 while 
are still present in Mut13-2. Hence, even if Mut13-2 expresses a truncated protein with a 
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single SN1 domain, it would not be able to have all the functions of a full-length TSN1 
protein. If the TSN1 protein is involved in RISC assembly and interacts with different 
components of the RISC and the RISC-loading complex, it is possible that a truncated 
TSN1 protein might not allow proper loading of small RNAs onto the RISC. On the other 
hand, a complete absence of TSN1 could lead to a loss of the small RNAs from the 
RISC-loading complex. In order to fully address such hypotheses, the role of TSN1 in 
small RNA binding could be further investigated in RNA co-immunoprecipitation 
experiments involving cross-linking between TSN1 and native RNA substrates. Future 
experiments with affinity purification of epitope-tagged TSN1 followed by SDS-PAGE 
and mass spectrometry analyses might reveal TSN1 interacting partners giving us an idea 
of its role in the RISC complex. It is also possible that the enhanced RNAi defects, like 
complete depletion of the miRNAs, in Mut20 result from the deletion of the HDAC 
Ankyrin repeat 3 domain. However, addressing these questions will require further 
characterization of the mutants and their specific RNAi defects. 
 
From our immunofluorescence microscopy studies, we found that epitope-tagged TSN1 
shows a predominant cytoplasmic localization in Mut20, which supports its association 
with the RISC as revealed from other studies in metazoans (8,11). Nonetheless, a nuclear 
role for the protein could not be ruled out from the immunofluorescence detection 
experiments, which agrees with the reported role of TSN1 in splicing and as a 
transcriptional co-activator (12-14). In addition, epitope-tagged TSN1 shows a broader 
distribution (including a possible nuclear localization) in the Mut13-2 complemented 
strains. It is possible that this subcellular localization is better reflective of a fully 
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functional TSN1 protein whereas the epitope tagged TSN1 might be partly mislocalized 
and, consequently, not fully functional in the Mut20 background. A low level of 
expression of the epitope-tagged TSN1 protein (in the Mut20 transformants) could also 
be a reason for the lack of complementation of Mut20, which might require higher 
expression levels of the protein for its proper function. 
 
Being a multi-functional protein, TSN1 is found to interact, in metazoans, with several 
other proteins such as EBNA-2 (13), c-Myb (15) and G3BP (16), but a specific RNAi 
component protein has not yet been characterized to associate with TSN1. In case of 
metazoans, TSN1 was found to be a part of the RISC along with other components such 
as Ago2, VIG and FXR (8). However, in our co-immunoprecipitation experiments, the 
epitope-tagged TSN1 did not seem to interact with the Chlamydomonas Argonaute 
polypeptide AGO3, which is an important component of the RISC and of the core RNAi 
machinery. This suggests that if TSN1 is a RISC component in Chlamydomonas, it does 
not appear to interact at high affinity with AGO3. 
 
Taken together, our results suggest that TSN1 is definitely involved in RNAi in 
Chlamydomonas reinhardtii and its deletion seems to result in a depletion of the 
endogenous miRNAs. It can be hypothesized that TSN1 might be involved in miRNA 
biogenesis or even have an accessory role in RISC assembly via loading of small RNAs 
onto Argonautes. Yet the specific molecular role of TSN1 in RNAi will require further 
investigation. 
 
 78 
Literature Cited 
 
1. Scherr, M. and Eder, M. (2004) RNAi in functional genomics. Curr Opin Mol 
Ther, 6, 129-135. 
2. Lanet, E., Delannoy, E., Sormani, R., Floris, M., Brodersen, P., Crete, P., 
Voinnet, O. and Robaglia, C. (2009) Biochemical evidence for translational 
repression by Arabidopsis microRNAs. Plant Cell, 21, 1762-1768. 
3. Nottrott, S., Simard, M.J. and Richter, J.D. (2006) Human let-7a miRNA blocks 
protein production on actively translating polyribosomes. Nat Struct Mol Biol, 13, 
1108-1114. 
4. Inui, M., Martello, G. and Piccolo, S. (2010) MicroRNA control of signal 
transduction. Nat Rev Mol Cell Biol, 11, 252-263. 
5. Krol, J., Loedige, I. and Filipowicz, W. (2010) The widespread regulation of 
microRNA biogenesis, function and decay. Nat Rev Genet, 11, 597-610. 
6. Vasudevan, S., Tong, Y. and Steitz, J.A. (2007) Switching from repression to 
activation: microRNAs can up-regulate translation. Science, 318, 1931-1934. 
7. Tomari, Y. (2009) Biochemical dissection of RISC assembly and function. 
Nucleic Acids Symp Ser (Oxf), 15. 
8. Caudy, A.A., Ketting, R.F., Hammond, S.M., Denli, A.M., Bathoorn, A.M., Tops, 
B.B., Silva, J.M., Myers, M.M., Hannon, G.J. and Plasterk, R.H. (2003) A 
micrococcal nuclease homologue in RNAi effector complexes. Nature, 425, 411-
414. 
9. Li, C.L., Yang, W.Z., Chen, Y.P. and Yuan, H.S. (2008) Structural and functional 
insights into human Tudor-SN, a key component linking RNA interference and 
editing. Nucleic Acids Res, 36, 3579-3589. 
10. Sundstrom, J.F., Vaculova, A., Smertenko, A.P., Savenkov, E.I., Golovko, A., 
Minina, E., Tiwari, B.S., Rodriguez-Nieto, S., Zamyatnin, A.A., Jr., Valineva, T. 
et al. (2009) Tudor staphylococcal nuclease is an evolutionarily conserved 
component of the programmed cell death degradome. Nat Cell Biol, 11, 1347-
1354. 
11. Scadden, A.D. (2005) The RISC subunit Tudor-SN binds to hyper-edited double-
stranded RNA and promotes its cleavage. Nat Struct Mol Biol, 12, 489-496. 
12. Paukku, K., Yang, J. and Silvennoinen, O. (2003) Tudor and nuclease-like 
domains containing protein p100 function as coactivators for signal transducer 
and activator of transcription 5. Mol Endocrinol, 17, 1805-1814. 
13. Tong, X., Drapkin, R., Yalamanchili, R., Mosialos, G. and Kieff, E. (1995) The 
Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel 
cellular coactivator that can interact with TFIIE. Mol Cell Biol, 15, 4735-4744. 
14. Valineva, T., Yang, J., Palovuori, R. and Silvennoinen, O. (2005) The 
transcriptional co-activator protein p100 recruits histone acetyltransferase activity 
to STAT6 and mediates interaction between the CREB-binding protein and 
STAT6. J Biol Chem, 280, 14989-14996. 
 79 
15. Leverson, J.D., Koskinen, P.J., Orrico, F.C., Rainio, E.M., Jalkanen, K.J., Dash, 
A.B., Eisenman, R.N. and Ness, S.A. (1998) Pim-1 kinase and p100 cooperate to 
enhance c-Myb activity. Mol Cell, 2, 417-425. 
16. Gao, X., Ge, L., Shao, J., Su, C., Zhao, H., Saarikettu, J., Yao, X., Yao, Z., 
Silvennoinen, O. and Yang, J. (2010) Tudor-SN interacts with and co-localizes 
with G3BP in stress granules under stress conditions. FEBS Lett, 584, 3525-3532. 
 
 
 
 
 
 
 
 
 
 
!
!
!
!
!
 
 
!
